Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-16-131282
Filing Date
2016-07-06
Accepted
2016-07-06 16:26:44
Documents
1
Effectiveness Date
2016-07-06

Document Format Files

Seq Description Document Type Size
1 DEFA14A a16-14486_1defa14a.htm DEFA14A 65346
  Complete submission text file 0001104659-16-131282.txt   66189
Mailing Address
Business Address 45 HARTWELL AVE LEXINGTON MA 02421 781-274-8200
SYNTA PHARMACEUTICALS CORP (Filer) CIK: 0001157601 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33277 | Film No.: 161754016
SIC: 2834 Pharmaceutical Preparations